McCarthy Secures Additional Funding for Valley Fever Research | News


The National Institutes of Health (NIH) recently announced $4.5 million in three grants to establish research centers focused on diagnostics, treatments and vaccines related to coccidioimycosis, also known as Valley Fever.

The action follows a September 2020 letter led by U.S. Congressmen Kevin McCarthy and David Schweikert of Arizona, co-chairs of the Congressional Valley Fever Task Force, which called on the NIH and the National Institute of Allergy and Infectious Diseases to fund valley fever research.

For years we have worked to alleviate and eradicate valley fever,” McCarthy said. “With Valley Fever cases continuing to rise, this funding comes at a critical time.

“I am happy to see that Dr. Royce Johnson and the Valley Fever Institute will be involved in these research efforts. I am grateful to my co-chair, Rep. Schweikert, for working with me on this issue over the years and to the NIH for focusing resources on diagnosis, development of treatments, and ultimately the eradication of valley fever.

Grants have been awarded to researchers at UC San Francisco, UCLA, and the University of Texas at San Antonio..

Kern Medical’s Valley Fever Institute will serve as a clinical assessment and recruiting center to advance Valley Fever research at research centers.

The Valley Fever Task Force’s top priority is securing funding for research that will bring us closer to fighting Valley Fever for good,” Schwiekert said. “Along with my Co-Chair, Minority Leader Kevin McCarthy, we have worked tirelessly to achieve this goal. I know we still have a long way to go in the fight to end Valley fever once and for all, and this funding for new research is a big step forward.

The $4.5 million funding announcement builds on the nearly $70 million the NIH has allocated for Valley fever research since the 2013 Bakersfield Valley Fever Symposium.

Congressman Kevin McCarthy has worked diligently to increase federal funding for Valley Fever research and reduce its impact on our communities,” said Dr. Royce Johnson, MD, FACP, Medical Director of the Valley Fever Institute. from Kern Medical. “His efforts recently led the National Institutes of Health to award funding that supports new research at the Valley Fever Institute.

This new research has the potential to transform our understanding of valley fever. We are grateful for the continued legislative advocacy of Valley Fever by Congressman McCarthy and the Congressional Valley Fever Task Force.


Comments are closed.